Ultragenyx Pharmaceutical Inc. (RARE) has seen some recent activity in the marketplace and its common shares were last quoted at $97.44 yesterday. Investors are starting to take interest of RARE as the common shares traded as high as $99.78 and as low as $90.03 in the previous trading session.
Ultragenyx Pharmaceutical Inc. (RARE) average trading volume is 337.82K. However, in the previous trading session Ultragenyx Pharmaceutical Inc. (RARE) traded 745,349 shares. The 1st support level on RARE is $97.40. RARE fifty day moving average is $86.33 and RARE 200day moving average is $78.19.
Ultragenyx Pharmaceutical Inc. (RARE) recent performance has been indicated by the recent movement in RARE common shares. RARE has performed 18.11% over the past 4 weeks, RARE has performed 27.79% over the past 3 months and RARE has shown 131.61% over the past 365 days. Ultragenyx Pharmaceutical Inc. (RARE) has a 1 year range of $31.99 to $99.79. Ultragenyx Pharmaceutical Inc. (RARE) is trading 204.60% from its 1 year low and -1.82% from its 1 year high. Ultragenyx Pharmaceutical Inc. (RARE) is showing a 12.31% short float showing the quantity short in the float.
RARE has 60.00M shares outstanding and 56.95M shares in the float. Ultragenyx Pharmaceutical Inc. (RARE) presently has a market cap of $5.83B and income of -300.50M. The EPS next quarter for RARE is -1.27 and projected EPS next year is 5.50%. The market cap of Ultragenyx Pharmaceutical Inc. (RARE) at $5.83B signifies how many Investors own shares of RARE and is based off the last price ($97.44) of RARE and the quantity of shares outstanding (60.00M) with Ultragenyx Pharmaceutical Inc. (RARE).
Ultragenyx Pharmaceutical Inc. (RARE) has total cash (mrq) of 813.42M, total cash per share (mrq) of 13.46, total debt of RARE rests at 43.57M and total debt/equity (mrq) is 6.26. . Ultragenyx Pharmaceutical Inc. (RARE) operational cash flow (ttm) is -168.35M, RARE leveraged free cash flow (ttm) is -67.88M.
RARE is trading 7.29% above (bullish) its SMA20, 13.93% above (bullish) its SMA50 and 38.95% above (bullish) its SMA200.